Atypical depression as a premonitory symptom of migraine managed by an oral contraceptive.
Kawamura
Satoshi
S
Sakai
Akio
A
Endo
Tomomichi
T
Maruta
Masaki
M
D000328:Adult; D000525:Alprazolam / Q000506:poisoning; D001883:Borderline Personality Disorder / Q000188:drug therapy / Q000523:psychology; D002121:Calcium Channel Blockers / Q000627:therapeutic use; D003277:Contraceptives, Oral, Combined / Q000627:therapeutic use*; D003865:Major Depressive Disorder / Q000175:diagnosis / Q000188:drug therapy* / Q000523:psychology; D004338:Drug Combinations; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D008656:Mestranol / Q000627:therapeutic use*; D020325:Migraine with Aura / Q000175:diagnosis / Q000188:drug therapy* / Q000523:psychology; D009640:Norethindrone / Q000627:therapeutic use*; D010879:Piperazines / Q000627:therapeutic use; D013406:Suicide, Attempted / Q000523:psychology; D014635:Valproic Acid / Q000627:therapeutic use
D002121:Calcium Channel Blockers; D003277:Contraceptives, Oral, Combined; D004338:Drug Combinations; D010879:Piperazines; D014635:Valproic Acid; C014715:Norinyl; D008656:Mestranol; C052424:lomerizine; D009640:Norethindrone; D000525:Alprazolam